Literature DB >> 3464912

Treatment of oral erosive lichen planus with systemic isotretinoin.

C Camisa, C M Allen.   

Abstract

Six patients with symptomatic oral erosive lichen planus were treated with systemic isotretinoin (10 to 60 mg daily) for 8 weeks. Five (83%) showed subjective and objective improvement at completion of therapy, but the improvement was slight. Relapse occurred in four patients within 2 months after the drug was stopped; one was lost to follow-up. Because of the minimal improvement and adverse side effects, no patient wished to be re-treated with isotretinoin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464912     DOI: 10.1016/0030-4220(86)90288-4

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  4 in total

Review 1.  Mouthwashes in the treatment of oral disease.

Authors:  D J Zegarelli
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  Pharmacological management of recurrent oral mucosal ulceration.

Authors:  J A Burgess; B D Johnson; E Sommers
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

Review 3.  Therapeutic strategies for oral lichen planus: State of the art and new insights.

Authors:  Dario Didona; Raffaele Dante Caposiena Caro; Antonio Manuel Sequeira Santos; Farzan Solimani; Michael Hertl
Journal:  Front Med (Lausanne)       Date:  2022-10-04

4.  Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.

Authors:  Sherman Chu; Lauren Michelle; Chloe Ekelem; Calvin T Sung; Nathan Rojek; Natasha A Mesinkovska
Journal:  Arch Dermatol Res       Date:  2020-11-05       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.